Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (6)

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2019

  1. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

    Endocrine, Vol. 64, Núm. 3, pp. 441-455

2017

  1. SNPs in bone-related miRNAs are associated with the osteoporotic phenotype

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis

    Maturitas, Vol. 82, Núm. 4, pp. 402-410

2012

  1. Results from a national survey on the management of primary hyperparathyroidism

    Journal of Endocrinological Investigation, Vol. 35, Núm. 11, pp. 957-963

  2. Risk factors for prediction of inadequate response to antiresorptives

    Journal of Bone and Mineral Research, Vol. 27, Núm. 4, pp. 817-824